Achilles Therapeutics Statistics Share Statistics Achilles Therapeutics has 41.1M
shares outstanding. The number of shares has increased by 0.03%
in one year.
Shares Outstanding 41.1M Shares Change (YoY) 0.03% Shares Change (QoQ) 0% Owned by Institutions (%) 60.1% Shares Floating 20.06M Failed to Deliver (FTD) Shares 5,471 FTD / Avg. Volume 0.43%
Short Selling Information The latest short interest is 1.5M, so 0% of the outstanding
shares have been sold short.
Short Interest 1.5M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.51 and the forward
PE ratio is -1.21.
Achilles Therapeutics's PEG ratio is
0.12.
PE Ratio -0.51 Forward PE -1.21 PS Ratio 0 Forward PS n/a PB Ratio 0.25 P/FCF Ratio -0.72 PEG Ratio 0.12
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Achilles Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 8.57,
with a Debt / Equity ratio of 0.03.
Current Ratio 8.57 Quick Ratio 8.57 Debt / Equity 0.03 Debt / EBITDA -0.07 Debt / FCF -0.09 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-341.5K Employee Count 204 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 491K Effective Tax Rate -0.71%
Stock Price Statistics The stock price has increased by 91.81% in the
last 52 weeks. The beta is 1.25, so Achilles Therapeutics's
price volatility has been higher than the market average.
Beta 1.25 52-Week Price Change 91.81% 50-Day Moving Average 1.32 200-Day Moving Average 1.02 Relative Strength Index (RSI) 76.37 Average Volume (20 Days) 1,281,745
Income Statement
Revenue n/a Gross Profit -4.73M Operating Income -75.25M Net Income -69.67M EBITDA -70.44M EBIT -75.16M Earnings Per Share (EPS) -1.74
Full Income Statement Balance Sheet The company has 131.54M in cash and 4.62M in
debt, giving a net cash position of 126.92M.
Cash & Cash Equivalents 131.54M Total Debt 4.62M Net Cash 126.92M Retained Earnings -259.95M Total Assets 122.68M Working Capital 93.16M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -48.45M
and capital expenditures -1.1M, giving a free cash flow of -49.55M.
Operating Cash Flow -48.45M Capital Expenditures -1.1M Free Cash Flow -49.55M FCF Per Share -1.24
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
